Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IFRX
Stock Latest News
Company Announcements
InflaRx Showcases Izicopan’s Renal Protection Data at Kidney Week 2026
35s ago
6K
IFRX
Premium
The Fly
InflaRx to present pre-clinical izicopan data at Kidney Week 2026
4h ago
IFRX
Premium
The Fly
InflaRx appoints Alperovich as SVP, Global Head of Clinical Development
21d ago
IFRX
Premium
The Fly
InflaRx initiated with a Buy at Needham
1M ago
IFRX
Premium
The Fly
InflaRx files $250M mixed securities shelf
3M ago
IFRX
Premium
Company Announcements
InflaRx Files Mid‑Year 2026 Unaudited Results in SEC Form 6‑K
3M ago
6K
IFRX
Premium
Company Announcements
InflaRx Moves to Broaden AAV Strategy in Europe After EMA Setback for Tavneos
4M ago
6K
IFRX
Premium
The Fly
InflaRx upgraded to Strong Buy from Outperform at Raymond James
5M ago
IFRX
Premium
The Fly
InflaRx price target raised to $8 from $6 at H.C. Wainwright
5M ago
IFRX
Premium
Company Announcements
InflaRx Raises $150 Million in Underwritten Share Offering Filed in Early May 2026
6M ago
6K
IFRX
Premium
The Fly
InflaRx to develop izicopan in AAV
6M ago
IFRX
Premium
Company Announcements
InflaRx Refocuses Izicopan on Vasculitis and Renal Diseases With Funding Runway to 2029
6M ago
6K
IFRX
Premium
Company Announcements
InflaRx Files Q1 2026 Financials with SEC via Form 6-K
6M ago
6K
IFRX
Premium
Company Announcements
InflaRx Highlights Favorable Safety-Signal Data for Izicopan in New Preclinical Study
6M ago
6K
IFRX
Premium
The Fly
InflaRx announces new izicopan pre-clinical data
6M ago
IFRX
Premium
Company Announcements
InflaRx Regains Nasdaq Minimum Bid Price Compliance, Securing Listing Status
6M ago
6K
IFRX
Premium
The Fly
InflaRx assumed with an Outperform at Oppenheimer
6M ago
IFRX
Premium
Company Announcements
InflaRx Shareholders Approve Capital, Governance Changes and 2026 Incentive Plan at April AGM
6M ago
6K
IFRX
Premium
Company Announcements
InflaRx Highlights New Izicopan Data Showing No CYP3A4 Time-Dependent Inhibition
7M ago
6K
IFRX
Premium
The Fly
InflaRx announces new izicopan in vitro findings
7M ago
IFRX
Premium
Company Announcements
InflaRx Sets April 23, 2026 AGM to Approve 2025 Accounts, Board Mandates and New LTIP
7M ago
6K
IFRX
Premium
The Fly
InflaRx presents vilobelimab data
7M ago
IFRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
